Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Staar Surgical (STAA)
NASDAQ:STAA
Staar Surgical (STAA) Stock Price & Analysis
506 Followers
STAA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$26.66 - $58.35
Previous Close$47.11
Volume785.67K
Average Volume (3M)558.23K
Market Cap
$2.31B
Enterprise Value$2.11B
Total Cash (Recent Filing)$245.15M
Total Debt (Recent Filing)$35.70M
Price to Earnings (P/E)152.3
Beta1.76
Next Earnings
Jul 31, 2024EPS Estimate
$0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.31
Shares Outstanding49,131,110
10 Day Avg. Volume609,901
30 Day Avg. Volume558,234
Standard Deviation0.18
R-Squared0.04
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)5.12
Price to Sales (P/S)26.25
Price to Cash Flow (P/CF)23.10
P/FCF Ratio30.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.45
Enterprise Value/Gross Profit8.33
Enterprise Value/Ebitda316.46
Forecast
1Y Price Target
$48.29Price Target Upside6.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Staar Surgical News
PremiumCompany Announcements
Staar Surgical Enhances Governance and Growth Strategy
PremiumCompany Announcements
Staar Surgical Hosts Investor Presentation Series
PremiumCompany Announcements
Staar Surgical Executives Discuss Q1 Results and 2024 OutlookBulls Say, Bears Say
Bulls Say
Financial Performance1Q results significantly above expectations with revenues of $77+ million, approximately 7% higher than the consensus estimate of $72 million.
Future OutlookFull-year revenue expectations are now at the high end of the company's previous guidance range, demonstrating confidence in the company's financial outlook.
Market PositionSurvey results show increasing traction in the US as refractive surgery gains more acceptance with more training, papers, and great outcomes.
Bears Say
Financial PerformanceEBITDA forecast for FY24 is slightly below management's guidance, suggesting caution regarding the company's profitability.
Future ProjectionsDespite strong guidance for 2024, the required growth to meet STAA's 2026 revenue target is seen as aggressive.
Revenue GrowthBears will point to low unit growth with the majority of revenue growth coming from pricing.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
STAA FAQ
What was Staar Surgical’s price range in the past 12 months?
Staar Surgical lowest stock price was $26.66 and its highest was $58.35 in the past 12 months.
What is Staar Surgical’s market cap?
Currently, no data Available
When is Staar Surgical’s upcoming earnings report date?
Staar Surgical’s upcoming earnings report date is Jul 31, 2024 which is in 10 days.
How were Staar Surgical’s earnings last quarter?
Staar Surgical released its earnings results on May 07, 2024. The company reported $0.107 earnings per share for the quarter, beating the consensus estimate of $0.061 by $0.046.
Is Staar Surgical overvalued?
According to Wall Street analysts Staar Surgical’s price is currently Undervalued.
Does Staar Surgical pay dividends?
Staar Surgical does not currently pay dividends.
What is Staar Surgical’s EPS estimate?
Staar Surgical’s EPS estimate is $0.24.
How many shares outstanding does Staar Surgical have?
Staar Surgical has 49,131,110 shares outstanding.
What happened to Staar Surgical’s price movement after its last earnings report?
Staar Surgical reported an EPS of $0.107 in its last earnings report, beating expectations of $0.061. Following the earnings report the stock price went down -12.069%.
Which hedge fund is a major shareholder of Staar Surgical?
Among the largest hedge funds holding Staar Surgical’s share is Bridgewater Associates, LP. It holds Staar Surgical’s shares valued at 2M.
---
Staar Surgical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$48.29 (6.79% Upside)
$48.29 (6.79% Upside)
Blogger Sentiment
Bullish
STAA Sentiment 83%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 763.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $42.6 over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.1%
Last 30 Days ▲ 2.8%
Last 30 Days ▲ 2.8%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-15.63%
12-Months-Change
Fundamentals
Return on Equity
4.18%
Trailing 12-Months
Asset Growth
17.58%
Trailing 12-Months
Company Description
Staar Surgical
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.
---
STAA Earnings Call
Q1 2024
0:00 / 0:00
---
STAA Stock 12 Month Forecast
Average Price Target
$48.29
▲(6.79% Upside)
Technical Analysis
Best Analysts Covering STAA
1 Year
1 Year Success Rate
5/7 ratings generated profit
1 Year Average Return
+15.41%
reiterated a buy rating 3 months ago
Copying Young Li's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +15.41% per trade.
---